ALEC
Alector, Inc.
Biological Products, (No Diagnostic Substances)- 売上
- $21m
- 時価総額
- $168m
株価 $1.52 · 100株 152円
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $97m | $101m | $21m |
| 成長率 | — | 3.6% | ▲79.1% |
| 総利益 | — | — | — |
| 総利益率 | — | — | — |
| 販管費 | $57m | $60m | $54m |
| 販管費率 | 58.4% | 59.3% | 256.5% |
| 営利 | ▲$152m | ▲$145m | ▲$156m |
| 営利率 | ▲156.3% | ▲144.2% | ▲741.3% |
| 純利益 | ▲$130m | ▲$119m | ▲$143m |
| PBR | 1.3 | 1.3 | 5.5 |
| PSR | 1.7 | 1.7 | 8.0 |
| PGPR | — | — | — |
| PER | — | — | — |
| ネットキャッシュ | $75m | $24m | $56m |
| EV/EBITDA | — | — | — |
| Rule of 40 | — | ▲141% | ▲820% |
| セールス効率 | — | — | — |
※Rule of 40は売上成長率+営業利益率、セールス効率は売上総利益増加÷販管費増加(販管費増のときのみ)
